Priority Date: 15.11.11 (US 201161560042P)

HCV NS3 PROTEASE INHIBITORS

  • Application ID: EP12850713
  • Status: EXAMINATION IN PROGRESS

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorneys

no operation time available
4 offices
Technology Company
no operation time available
7 offices
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Merck & Co. Inc. and Merck Sharp & Dohme Ltd. are specialized in A61. Merck & Co. Inc., Merck Sharp & Dohme Ltd. is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 15.11.2011 - Priority Date (US 201161560042P)
  • 23.05.2013 - Publication A2 (WO2013074386)
  • 24.09.2014 - Publication A2 (EP2780026)

IPC Classification